Healthcare -
Biotechnology - NASDAQ - US
$ 3.35
0.601 %
$ 2.33 M
Market Cap
0.0
P/E
RNAZ - TOTAL CURRENT ASSETS
Total Current Assets RNAZ - TransCode Therapeutics, Inc.
4.46 M
LAST VALUE
-55.73%
2 YEAR CAGR
83.41%
5 YEAR CAGR
0.00%
10 YEAR CAGR